Organize key development questions before target-animal studies.

Feline chronic kidney disease is one of the most important areas in companion animal health. However, product development in this field requires careful planning before moving into target-animal studies.

Before advancing to feline studies, development teams often need to clarify key questions such as mechanism of action, dose rationale, candidate selection, biomarkers, endpoints, and Go / No-Go criteria.

KGAH-ONE supports Animal Health companies by organizing these development questions and helping teams design a more prepared nonclinical evaluation strategy.

KGAH organizes development decisions.
SMC Laboratories generates preclinical data.

Together, this support does not replace target-animal studies. Instead, it helps development teams enter them with clearer scientific questions, better-defined evaluation plans, and stronger nonclinical evidence.

How KGAH Supports Feline CKD Development

KGAH-ONE helps teams clarify:

• ● What development question should be answered before target-animal studies
• ● Which candidate or formulation should be prioritized
• ● What mechanism or biological pathway should be evaluated
• ● Which nonclinical endpoints may support decision-making
• ● How early data can inform Go / No-Go decisions

How SMC Laboratories Supports Nonclinical Data Generation

SMC Laboratories can support nonclinical evaluation by generating data using disease models relevant to kidney injury, fibrosis, inflammation, and renal function.

For CKD-related development, the adenine-induced CKD mouse model may be used to evaluate renal injury, fibrosis, inflammation, biochemical parameters, and histological changes.

This model is not a substitute for feline studies. It can be used as one part of a broader decision-support strategy before advancing to target-animal evaluation.

Potential Applications

This approach may be relevant for:

• ● Therapeutic candidates
• ● Supplements
• ● Functional ingredients
• ● Renal diets
• ● Combination approaches
• ● Early-stage product concepts

Discuss Nonclinical Evaluation Strategy

If you are developing a feline CKD-related product and would like to organize your preclinical evaluation strategy before target-animal studies, please contact KGAH-ONE to discuss your nonclinical evaluation strategy.